|
|
|
|
Vol. 8, Issue 11, 2101-2109, November 1997
Department of Biology, University of Utah, Salt Lake City, Utah 84112
The predatory cone snails (Conus) are among the most successful living marine animals (~500 living species). Each Conus species is a specialist in neuropharmacology, and uses venom to capture prey, to escape from and defend against predators and possibly to deter competitors. An individual cone snail's venom contains a diverse mixture of pharmacological agents, mostly small, structurally constrained peptides (conotoxins). Individual peptides are selectively targeted to a specific isoform of receptor or ion channel. A variety of such targets have been identified, including many voltage-gated and ligand-gated ion channel subtypes, as well as G protein-linked receptors. Although there are only a few widely shared structural motifs in conotoxins (the majority of the >25,000 peptides in these venoms probably belong to only half a dozen gene superfamilies), the sequences of peptides are remarkably divergent from one Conus species to another. We suggest that cone snails undergoing speciation have, in effect, a mutator phenotype which acts specifically on the gene segment encoding the mature toxin region. In their 50 million years of evolution, cone snails anticipated many features of the modern drug industry: disposable hypodermic needles, combination drug therapy, and combinatorial strategies for drug discovery. Recent results indicate that the Conus peptide system may provide a novel paradigm for designing ligands that discriminate between closely related members of large families of receptors and ion channels. Many Conus peptides may be "Janus-ligands," with two distinct recognition faces oriented in different directions, a design which should make far greater target specificity possible.
| |
BIOLOGY OF CONE SNAILS: WHY A NEUROPHARMACOLOGICAL STRATEGY? |
|---|
The carnivorous cone snails (Fig. 1)
are relatively young in evolutionary terms; the first fossil
Conus appear only after dinosaurs went extinct (Kohn, 1990
).
However, they comprise what is arguably the largest single genus of
marine animals living today. All cone snails are venomous predators. It
is quite likely that most Conus use their venoms for
multiple purposes, including prey capture and defense. All 500 living
species of cone snails (Kohn, 1976
; Röckel et al.,
1995
) have a highly sophisticated venom production apparatus and
delivery system (Fig. 2). A hallmark of
the latter is the specialized teeth, which in effect serve both as
harpoon and disposable hypodermic needle for venom delivery (Kohn
et al., 1960
; Kohn et al., 1972
).
|
|
Although most Conus move considerably faster than would be
expected of the proverbial snail, they remain relatively slow compared to other ambulatory predators. Cone snails cannot swim; despite this, a
significant number have evolved to feed primarily (if not exclusively)
on fish (Kohn, 1956
). For a predator with these locomotory
disadvantages to specialize in such agile prey requires an unusual
venom: once the fish-hunting snail strikes its prey, extremely rapid
and effective immobilization usually occurs. Given this background
biology, it becomes easy to rationalize why the major venom
components characterized so far have been found to target key cell
surface-signaling components of nervous systems, i.e., ion channels and
receptors (Olivera et al., 1985
, 1990
). Slow-moving or
sessile venomous predators would have particular need for extremely
fast-acting venoms, a scenario favoring evolution of toxins which
target nervous systems.
Several features of cone snail venoms have been firmly established in
recent years. First, the venoms are extremely complex
venom from an
individual Conus may have 50-200 distinct, biologically active components. Most of these are small peptides (6-40 amino acids
in length), with the majority being in the size range of 12-30 amino
acids (see Olivera et al., 1990
). Although Conus
toxins are unusually small, they are invariably highly constrained
conformationally. Most are extensively cross-linked through multiple
intramolecular disulfide linkages, although other
conformation-constraining strategies, such as the presence of an
unusual
-helix-stabilizing posttranslational modification (McIntosh
et al., 1984
; Myers et al., 1990
; Olivera et al., 1990
) have been discovered.
The complement of peptides found in any one Conus venom is strikingly different from that found in the venom of any other Conus species. Thus, in the whole genus, many tens of thousands of distinct pharmacologically active peptides have been evolved. A question which immediately arises is why individual cone snails should need so many different peptides. We speculate that the complement of peptides in a venom may be used for at least three general purposes. An individual peptide may play a role in 1) prey capture, directly or indirectly; 2) defense and escape from predators; or 3) other biological phenomena (such as interaction with potential competitors, for example).
| |
CONE SNAILS CAPTURE PREY USING A COMBINATION DRUG STRATEGY |
|---|
Although each of the 500 different cone snail species is usually highly specialized with respect to prey, the genus as a whole envenomates a surprisingly broad range of prey types. The largest group of Conus (>150 species) probably hunt various polychaete worms. However, a substantial number (ca. 70) prey on fish and another ~70 specialize on molluscs. In addition, a number of Conus species feed on hemichordates and echiuroids. By far the best understood in terms of molecular mechanisms are the fish-hunting cone snails.
Fish-hunting cone snails can generally be divided into two broad
classes: "hook-and-line" fishing snails, which use their long
probosces to harpoon prey with a disposable harpoon-like tooth (which
also serves as a hypodermic needle) and "net-fishing" cone snails,
which engulf prey with a large distensible mouth before stinging (Fig.
3). Among the latter is the geography
cone, Conus geographus, the species most lethal to man
70%
of untreated human stinging cases are fatal (Cruz and White, 1995
).
Although a hook-and-line strategy would permit prey capture at a
greater distance, the potential advantage of net fishing is that it
becomes possible to bag a whole school of smaller fish at one time.
|
For Conus purpurascens, which uses a hook-and-line
strategy to capture fish, the injected venom has been shown to
sequentially elicit two distinct immobilization phases, excitotoxic
shock followed by neuromuscular block (Terlau et al., 1996
).
In effect, one group of peptides hyperexcites targeted electrically
excitable cells around the venom injection site, whereas a second group
of peptide toxins suppresses the motor circuitry of the prey. The first
physiological effect, excitotoxic shock, requires the combined action
of a peptide which prevents voltage-gated sodium channels from closing
once they have opened, thereby increasing the influx of sodium (Shon et al., 1995
) and a second toxin which blocks certain
subtypes of potassium channels, thereby inhibiting potassium efflux
(Terlau et al., 1996
). The combination of increased sodium
influx and decreased potassium efflux results in the massive
depolarization of neuronal circuitry at the injection site. This has
the effect of stunning the fish almost instantaneously upon venom
injection.
A second, nonoverlapping, group of toxins in the same venom
consists of peptides that act synergistically to block neuromuscular transmission. All fish-hunting Conus have a subset of such
toxins, which typically include 1) a group of peptides which antagonize different subtypes of presynaptic voltage-gated calcium channels (Olivera et al., 1994
) and thereby inhibit neurotransmitter
release; 2) competitive and noncompetitive antagonists of the
postsynaptic nicotinic acetylcholine receptor (Gray et al.,
1984; Shon et al., 1997a
) that prevent depolarization at the
muscle end plate; and 3) skeletal muscle voltage-gated sodium channel
blockers which act like tetrodotoxin (Spence et al., 1977
;
Stone and Gray, 1982
; Nakamura et al., 1983
; Sato et
al., 1983
; Cruz et al., 1985
); these directly abolish
muscle action potentials. Most piscivorous Conus have three
or four different major peptides which, by acting together, very
efficiently wipe out the motor circuitry of the fish prey. The
concerted action of this second group is shown in Fig.
4.
|
The first group of toxins act at the venom injection site to stun prey. Thus, the fish is immobilized during the lag time required for the second group of toxins to reach their targets in the neuromuscular system. By having both groups of toxins, the snail maximizes the probability that the fish will be continuously immobilized after it has been stung, thereby increasing the likelihood that prey will be captured. Both general physiological strategies (stunning the fish by excitotoxic shock, paralysis by neuromuscular block) require the synergistic action of multiple peptides. We refer to such functionally linked groups of peptides acting together as "toxin cabals." The toxins which cause excitotoxic shock together comprise the "lightning-strike cabal" while those causing neuromuscular block are designated the "motor cabal."
A modern development in pharmacology which has attracted considerable attention is the use of combination drug therapy, particularly for more intractable health problems such as AIDS or incurable tumors. The cone snails appear to have anticipated the development of pharmacological combination strategies by over 40 million years. The peptides which contribute to excitotoxic shock (the lightning-strike cabal) as well as the peptides that disrupt neuromuscular transmission (the motor cabal) comprise, in effect, a highly sophisticated application of a combination drug strategy in a natural system. (Since the relevant "drugs" are hardly beneficial to the prey, it seems inappropriate to refer to this as combination drug "therapy").
In addition to the two toxin cabals directly involved in prey
immobilization, other venom peptides may play accessory roles to
enhance the probability of prey capture. For example, there is evidence
for peptides that suppress the fight-or-flight response of the fish
prey (Cartier et al., 1996; Tavazoie et al.,
1997
). In addition, vasopressin-like peptides which constrict arteries may promote more rapid uptake of paralytic peptides of the motor cabal
by the capillary bed (Cruz et al., 1987
). The impression created by the pharmacological characterization carried out so far is
of an extremely strong selection pressure for very rapid prey
immobilization and a biological system able to mount a sophisticated response in evolutionary time to address this pressure.
| |
GENERATING NEUROPHARMACOLOGICAL DIVERSITY THROUGH A COMBINATORIAL LIBRARY SEARCH STRATEGY |
|---|
As more Conus peptides have been analyzed, it has become apparent that the venoms from different species have peptides surprisingly divergent in sequence from each other. Very rapid evolution of novel venom components has apparently occurred during the radiation of these molluscs in the last ~50 million years. As a result, homologous peptides from different species often have diverged to the point of making any sequence similarity unrecognizable. This is illustrated by the structurally diverse peptides shown in Fig. 5, all of which inhibit the postsynaptic nicotinic acetylcholine receptor at the neuromuscular junction.
|
Although the molecular mechanisms that lead to rapid interspecific
divergence are not understood, the phenomenon has become better
defined. Conus peptides are initially translated as larger prepropeptide precursors; a mature Conus peptide of 20 amino
acids is generally processed from a 70 to 80 amino acid precursor, with a single nonrepeated copy of the toxin encoded at the C-terminal end
(Woodward et al., 1990
; Colledge et al., 1992
).
Peptide diversification apparently arises by focal hypermutation of the
C-terminal toxin-encoding region while the rest of the precursor
sequence remains largely conserved. The most conserved sequence feature
of all is the signal sequence (Fig. 6).
|
In many ways, the pattern of conserved and variable regions in
Conus peptide precursors is opposite that of conventional
secreted polypeptides. Two Conus peptide precursors,
-conotoxins MVIIA and GVIA (Olivera et
al., 1984
, 1987
) from two different fish-hunting cone snails, are
compared in Fig. 6. These two
-conotoxins target precisely the same
site on an
1B subunit of a voltage-gated calcium channel. Total sequence conservation might have been predicted for two
such peptides that both target the same site and are found in species
in the same genus. In contrast, we would not, a priori, expect signal sequence conservation (in most secreted proteins, the
N-terminal signal region is the least conserved sequence element). The
reality (Fig. 6) is the converse of these expectations: the signal
sequence region is completely conserved, but the mature toxins show
extreme divergence in sequence (
30% of noncysteine amino acids
conserved). This juxtaposition of conserved and hypervariable regions
within the same translation product is reminiscent of antibody-encoding
genes in the mammalian immune system, where special genetic mechanisms
have evolved to generate diversity.
In the midst of the C-terminal toxin region which is generally hypervariable, the cysteine residues involved in the disulfide framework of the mature toxin are totally conserved. It is noteworthy that many conotoxin N-terminal signal sequences contain one or two cysteine residues (for example, those shown in Fig. 6), whereas the longer intervening propeptide region (between signal sequence and C-terminal mature toxin peptide) never has any Cys residues. The extremely conserved signal sequence may be optimally designed to target the precursor to a specific region in the endoplasmic reticulum; this may be important for specific posttranslational modifications as well as sorting into specialized secretory vesicles. In addition, however, the presence of Cys residues in many signal sequences suggests that signal sequences may also play a sequestration role, i.e., to avoid premature or inappropriate disulfide bond formation in the mature toxin region. The latter hypothesis predicts that a mutation either in a Cys residue in the mature toxin region or in the signal sequence may perturb proper processing and secretion. Such mutations would be selected against at the cellular processing level, resulting in a coconservation of N-terminal signal sequences and Cys residues in the C-terminal toxin region. Thus, rapid toxin evolution may occur via a pathway in which conservation of structural frameworks based on Cys residues is selected for, even at the level of cellular processing of precursors.
Rapid hypermutation of venom peptides could be an optimum evolutionary
strategy when prey, predators, and competitors change very rapidly (due
to a sudden climate change or geological catastrophe, for example).
Special mechanisms may have evolved that accelerate the generation of
new venom peptides
in effect, by hypermutating the variable sequences
between disulfide frameworks, cone snails employ a combinatorial
library search strategy to evolve new peptides in their venoms.
Although hypermutation of peptide sequences is undoubtedly the main
engine for generating peptide diversity in Conus, an
unprecedented series of posttranslational modifications provide an
overlying level of diversity (Jimenez et al., 1997
). Some of
these modifications (such as epimerization of L-tryptophan
to D-tryptophan and posttranslational bromination of Trp to
6-Br-tryptophan) have not been described previously outside the
Conus peptide system. Others (i.e.,
-carboxylation of
glutamate to
-carboxyglutamate) were described previously only in
specialized, phylogenetically distant systems. One recently characterized small Conus peptide may be the most
intensively posttranslationally modified polypeptide known: six
posttranslational modifications occur in the mature toxin region to
generate the final functional gene product of only eight amino acids
(Jimenez et al., 1997
). In some cases, posttranslational
modification occurs to constrain Conus peptide conformation.
For example, the posttranslational
-carboxylation of glutamate
residues (McIntosh et al., 1984
) strongly promotes formation
of an
-helix in at least some Conus peptides (Myers
et al., 1990
).
| |
EVOLVING HIGHLY REFINED TARGETING |
|---|
One important trend in modern drug development is to refine drug target specificity. Particularly for pharmacological agents that need to be applied chronically, severe side effects are a continuing problem. A current research imperative is to develop "clean drugs" that only target the therapeutically relevant molecule and not other closely related subtypes. In this respect, cone snails excel greatly compared to what the drug industry can produce at the present time. The Conus peptide system may help to reveal molecular recognition principles that underlie highly refined targeting.
In almost every case that has been carefully examined, Conus
peptides appear to be much more selective than other ligands targeting
the same receptor. Thus, the major paralytic
-conotoxin series in
fish-hunting cone snail venoms (such as
-conotoxin GI
shown in Fig. 5) discriminate between the two ligand-binding sites on
the nicotinic acetylcholine receptor by three to four orders of
magnitude; in contrast, analogous snake toxins such as
-bungarotoxin
have affinities that differ little for the two ligand-binding sites.
Additionally, the snake toxins target certain neuronal nicotinic
receptors (belonging to the
7 subtype)
these are not targeted at
all by the
-conotoxins. Thus, this group of
-conotoxins may be
the most specifically targeted nicotinic antagonists known. Another
example of exceptionally selective targeting are the µ-conotoxins,
which exhibit much more specificity for particular sodium channel
subtypes (i.e., those of skeletal muscle) than do the classical
guanidinium toxins, tetrodotoxin and saxitoxin.
Why are Conus peptides exceptionally selective for their
receptor targets? Two reasons are suggested by cone snail biology. The
necessity for very rapid prey immobilization would provide strong
selection pressure for ligands not to bind physiologically irrelevant targets. Binding to other molecules with
KDs < 0.1 µM could mean multiple rounds
of association and dissociation en route to the true physiological
receptors. This would cause a lag before the peptide could elicit its
biological effect. In addition, increasing venom complexity raises the
probability that two peptides in the same venom would jam each other's
function physiologically, a possibility greatly diminished if venom
peptides were narrowly targeted. In the work on C. purpurascens venom described above (Terlau et al.,
1996
), one peptide increases total inflow of sodium
through voltage-gated sodium channels (part of the lightning strike
cabal), where another peptide blocks conductance through sodium channels (part of the motor cabal). Clearly, the two peptides would act at cross purposes if they were to act on sodium channels of
the same cells. In fact, each peptide is targeted with great specificity to different molecular forms of voltage-gated sodium channels located in distinct populations of cells. Consequently, in
vivo, no functional interference occurs between these two potentially antagonistic venom components.
The specificity of Conus toxins can be very impressive
indeed. In the case of voltage-gated Ca2+ channel-targeted
toxins (such as
-conotoxins GVIA or MVIIA) discrimination between various calcium channel subtypes can be >106-fold (Olivera et al., 1994
). The ability
to discriminate between closely related members of the calcium channel
family is being exploited medically to develop one Conus
peptide,
-conotoxin MVIIA as a drug for the alleviation
of intractable pain. Within the spinal cord, the targeted
1B-containing voltage-gated calcium channel complexes
are largely restricted to sensory regions. The high degree of target
discrimination exhibited by this peptide has made it a feasible
candidate for drug development; it is now in advanced clinical trials
(Bowersox et al., 1997
). In addition, a class of
subtype-specific N-methyl-D-aspartate receptor
antagonists, the conantokins, exhibit unique properties that give them
considerable potential for development as anticonvulsant drugs (White
et al., 1997
).
A major question which needs to be investigated further are the
mechanisms by which Conus peptides discriminate among target subtypes. Recently, evidence obtained by my colleagues J. Michael McIntosh, G. Edward Cartier, and Doju Yoshikami on a conotoxin whose
structure was solved by Shon et al. (1997b)
suggests a
"dock-and-lock" recognition mechanism. The very high subtype
selectivity of this Conus peptide appears to arise from the
presence of two distinct interaction faces, called the "docking"
and the "locking" faces, which in turn interact with complementary
docking and locking sites on the target receptor. The experimental
results are consistent with initial contact being made by the docking
face on the peptide interacting with a docking site on the receptor;
this then facilitates formation of functionally significant locking
interactions of the toxin locking face with the receptor locking site.
We have coined the term "Janus-ligand" when, as in the example above, two interaction faces are present that are oriented in different directions (after Janus, the two-faced Roman god of beginnings). This could provide a basis for much more refined discrimination between homologous members of a large receptor or ion channel family. We suggest that many Conus peptides may be similarly two-faced Janus-ligands that use a strategically different molecular recognition paradigm from "normal" ligands. Other novel design strategies for subtype discrimination may well have evolved in these venoms.
| |
CONE SNAIL PEPTIDES: AN HISTORICAL VIEW |
|---|
A plausible scenario can be constructed for how cone snails may have evolved their complex venoms over the last 50 million years. Once the first venom able to cause prey paralysis by targeting a key component of the nervous system had evolved, a gradual expansion of the pharmacopoeia to yield more and more effective venom for prey immobilization may have taken place (this could well have occurred in taxa ancestral to Conus). Additionally, any venom components that could be used defensively would confer a strong selective advantage. As the venoms of Conus species slowly assumed greater complexity with time, these would then be subject to more selective variables.
With increasing venom complexity, a successive series of sudden changes
in the environment would be expected to provide a correspondingly
greater advantage to species that could mutate their venoms relatively
quickly to adapt to a new ecological context, providing a
"first-out-of-the-gate" evolutionary advantage. This is quite
analogous to the observation (LeClerc et al., 1996
) that pathological microorganisms that have recently colonized new hosts have
a much higher frequency of the mut phenotype, which
confers a greatly increased frequency of mutation. Furthermore, when
successive rounds of strong selection are applied in vitro, an entire
bacterial population is found with the hypermutagenic mut
phenotype (Mao et al., 1997
). We suggest that successive
extreme changes in climate and/or geological catastrophes may similarly
select for hypermutation phenotypes in macroorganisms,
with Conus peptides being an extreme example. The ability of
cone snails to rapidly evolve a new complement of peptides after a
geological catastrophe may be the key factor in the species richness of
the genus Conus at the present time.
Our historical reconstruction predicts that for the last 50 million years peptides selected for one set of prey or predators may have had to be successively (and rapidly, in a geological time scale) mutagenized, thus generating a new set of peptides optimized to a different ecological context. However, receptors and ion channels in different nervous systems are quite conserved. Thus, a ligand for a nicotinic receptor targeted to emerging new prey would most likely be derived by mutagenesis from a gene encoding a ligand for nicotinic receptors in the original biological context, to take a specific example. Thus, a nicotinic receptor antagonist in a present-day cone snail venom may, in the course of its geological history, have undergone multiple rounds of selection for optimally targeting nicotinic receptors in different animals and even for different nicotinic receptor subtypes.
Thus, over tens of millions of years, the ligands present in
Conus venoms may, in effect, have been subject to multiple
rounds of selection against a target receptor family. Janus-ligands may be one consequence of such reiterative selection over evolutionary time. Much of the molecular diversity in all nervous systems stems from
assembling macromolecular complexes in a modular and combinatorial fashion. Heteromeric complexes are characteristic of both ligand-gated ion channels (such as the nicotinic receptor) or voltage-gated channels
(such as K+ channels) with subunit interfaces of the type
x
y where
x and
y may represent members of two different
gene families with many homologues (
1,
2,
3 ... etc., and
1,
2,
3, etc.). The functional receptor or ion channel complex
is typically a tetrameric or pentameric combination of specific
and
subunits. Ordinary ligands would generally target any receptor
complex which contained a high-affinity subunit target (such as
x).
Janus-ligands with two different interaction faces would be one
structural design adaptation that would be favored by reiterative
rounds of selection for targets with a modular organization. Because a
Janus-ligand has two distinct recognition interfaces, it would have
much higher specificity (i.e., of the
x-containing complexes, only
those specifically containing adjacent
x
y subunits would be high
affinity targets); this would pick out a specific target isoform from
many closely related ones in a large family of heteromeric receptors or
ion channels. There is much that remains to be understood about the venom system and individual venom peptides observed in cone snails today; it seems wise to keep in mind that these are the end result of
the historical forces described above.
| |
ACKNOWLEDGMENTS |
|---|
I acknowledge with deep appreciation the consistent support of the National Institute of General Medical Sciences (PO1-GM-48677). This essay would not have been possible without the contributions of my collaborators at the University of Utah as well as those of many scientific colleagues at other institutions who have participated in the Conus peptide project.
| |
FOOTNOTES |
|---|
* The E.E. Just Lecture was presented on December 8, 1996, in San Francisco, California, at the joint meeting of the 6th International Congress on Cell Biology and the 36th American Society for Cell Biology Annual Meeting.
| |
REFERENCES |
|---|
|
|
|---|
-conotoxin which targets
3
2 nicotinic acetylcholine receptors.
J. Biol. Chem.
271, 7522-7528
-conotoxin GVIA determined from a cDNA clone.
Toxicon
30, 1111-1116[Medline].
-Conotoxin EI, a new nicotinic acetylcholine receptor-targeted peptide.
Biochemistry
34, 14519-14526[Medline].
-Carboxyglutamate in a neuroactive toxin.
J. Biol. Chem.
259, 14343-14346
-conotoxin from Conus magus venom.
Biochemistry
26, 2086-2090[Medline].
-conotoxins and
-agatoxins.
Annu. Rev. Biochem.
63, 823-867[Medline].
- and
-conotoxins from Conus striatus venom.
Biochemistry
31, 9919-9926[Medline].
-conotoxin
MII, an
3
2 neuronal nicotinic acetylcholine
receptor-targeted ligand. Biochemistry (in press).
-conotoxins MII and ImI.
Br. J. Pharmacol.
120, 995-1000[Medline].This article has been cited by other articles:
![]() |
Q. Kaas, J.-C. Westermann, R. Halai, C. K. L. Wang, and D. J. Craik ConoServer, a database for conopeptide sequences and structures Bioinformatics, February 1, 2008; 24(3): 445 - 446. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Olivera and R. W. Teichert Diversity of the Neurotoxic Conus Peptides: A Model for Concerted Pharmacological Discovery Mol. Interv., October 1, 2007; 7(5): 251 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Alex, A. J. Baucum, and K. S. Wilcox Effect of Conantokin G on NMDA Receptor-Mediated Spontaneous EPSCs in Cultured Cortical Neurons J Neurophysiol, September 1, 2006; 96(3): 1084 - 1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Jakubowski, W. P. Kelley, J. V. Sweedler, W. F. Gilly, and J. R. Schulz Intraspecific variation of venom injected by fish-hunting Conus snails J. Exp. Biol., August 1, 2005; 208(15): 2873 - 2883. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Kelly, C. T. Beuckmann, S. C. Williams, C. M. Sinton, T. Motoike, J. A. Richardson, R. E. Hammer, M. G. Garry, and M. Yanagisawa From the Cover: Neuropeptide B-deficient mice demonstrate hyperalgesia in response to inflammatory pain PNAS, July 12, 2005; 102(28): 9942 - 9947. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Schulz, A. G. Norton, and W. F. Gilly The Projectile Tooth of a Fish-Hunting Cone Snail: Conus catus Injects Venom Into Fish Prey Using a High-Speed Ballistic Mechanism Biol. Bull., October 1, 2004; 207(2): 77 - 79. [Full Text] [PDF] |
||||
![]() |
A. D. Santos, J. M. McIntosh, D. R. Hillyard, L. J. Cruz, and B. M. Olivera The A-superfamily of Conotoxins: STRUCTURAL AND FUNCTIONAL DIVERGENCE J. Biol. Chem., April 23, 2004; 279(17): 17596 - 17606. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Barbier, H. Lamthanh, F. Le Gall, P. Favreau, E. Benoit, H. Chen, N. Gilles, N. Ilan, S. H. Heinemann, D. Gordon, et al. A {delta}-Conotoxin from Conus ermineus Venom Inhibits Inactivation in Vertebrate Neuronal Na+ Channels but Not in Skeletal and Cardiac Muscles J. Biol. Chem., February 6, 2004; 279(6): 4680 - 4685. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. TERLAU and B. M. OLIVERA Conus Venoms: A Rich Source of Novel Ion Channel-Targeted Peptides Physiol Rev, January 1, 2004; 84(1): 41 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Inceoglu, J. Lango, J. Jing, L. Chen, F. Doymaz, I. N. Pessah, and B. D. Hammock One scorpion, two venoms: Prevenom of Parabuthus transvaalicus acts as an alternative type of venom with distinct mechanism of action PNAS, February 4, 2003; 100(3): 922 - 927. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ferber, A. Sporning, G. Jeserich, R. DeLaCruz, M. Watkins, B. M. Olivera, and H. Terlau A Novel Conus Peptide Ligand for K+ Channels J. Biol. Chem., January 17, 2003; 278(4): 2177 - 2183. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ellison, J. M. McIntosh, and B. M. Olivera alpha -Conotoxins ImI and ImII. SIMILAR alpha 7 NICOTINIC RECEPTOR ANTAGONISTS ACT AT DIFFERENT SITES J. Biol. Chem., January 3, 2003; 278(2): 757 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Dutton, P. S. Bansal, R. C. Hogg, D. J. Adams, P. F. Alewood, and D. J. Craik A New Level of Conotoxin Diversity, a Non-native Disulfide Bond Connectivity in alpha -Conotoxin AuIB Reduces Structural Definition but Increases Biological Activity J. Biol. Chem., December 6, 2002; 277(50): 48849 - 48857. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ouanounou, M. Malo, J. Stinnakre, A. S. Kreger, and J. Molgo Trachynilysin, a Neurosecretory Protein Isolated from Stonefish (Synanceia trachynis) Venom, Forms Nonselective Pores in the Membrane of NG108-15 Cells J. Biol. Chem., October 11, 2002; 277(42): 39119 - 39127. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Marshall, W. P. Kelley, S. S. Rubakhin, J.-P. Bingham, J. V. Sweedler, and W. F. Gilly Anatomical Correlates of Venom Production in Conus californicus Biol. Bull., August 1, 2002; 203(1): 27 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. McDonough, L. M. Boland, I. M. Mintz, and B. P. Bean Interactions among Toxins That Inhibit N-type and P-type Calcium Channels J. Gen. Physiol., March 12, 2002; 119(4): 313 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Donevan and R. T. McCabe Conantokin G Is an NR2B-Selective Competitive Antagonist of N-Methyl-D-aspartate Receptors Mol. Pharmacol., September 1, 2000; 58(3): 614 - 623. [Abstract] [Full Text] |
||||
![]() |
B. E. Wright A Biochemical Mechanism for Nonrandom Mutations and Evolution J. Bacteriol., June 1, 2000; 182(11): 2993 - 3001. [Full Text] |
||||
![]() |
H. S. White, R. T. McCabe, H. Armstrong, S. D. Donevan, L. J. Cruz, F. C. Abogadie, J. Torres, J. E. Rivier, I. Paarmann, M. Hollmann, et al. In Vitro and In Vivo Characterization of Conantokin-R, a Selective Nmda Receptor Antagonist Isolated from the Venom of the Fish-Hunting Snail Conus radiatus1 J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 425 - 432. [Abstract] [Full Text] |
||||
![]() |
C. S. Walker, D. Steel, R. B. Jacobsen, M. B. Lirazan, L. J. Cruz, D. Hooper, R. Shetty, R. C. DelaCruz, J. S. Nielsen, L. M. Zhou, et al. The T-superfamily of Conotoxins J. Biol. Chem., October 22, 1999; 274(43): 30664 - 30671. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Craig, T. Norberg, D. Griffin, C. Hoeger, M. Akhtar, K. Schmidt, W. Low, J. Dykert, E. Richelson, V. Navarro, et al. Contulakin-G, an O-Glycosylated Invertebrate Neurotensin J. Biol. Chem., May 14, 1999; 274(20): 13752 - 13759. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Rigby, E. Lucas-Meunier, D. E. Kalume, E. Czerwiec, B. Hambe, I. Dahlqvist, P. Fossier, G. Baux, P. Roepstorff, J. D. Baleja, et al. A conotoxin from Conus textile with unusual posttranslational modifications reduces presynaptic Ca2+ influx PNAS, May 11, 1999; 96(10): 5758 - 5763. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. England, J. Imperial, R. Jacobsen, A. G. Craig, J. Gulyas, M. Akhtar, J. Rivier, D. Julius, and B. M. Olivera Inactivation of a Serotonin-Gated Ion Channel by a Polypeptide Toxin from Marine Snails Science, July 24, 1998; 281(5376): 575 - 578. [Abstract] [Full Text] |
||||
![]() |
R. B. Jacobsen, E. D. Koch, B. Lange-Malecki, M. Stocker, J. Verhey, R. M. Van Wagoner, A. Vyazovkina, B. M. Olivera, and H. Terlau Single Amino Acid Substitutions in kappa -Conotoxin PVIIA Disrupt Interaction with the Shaker K+ Channel J. Biol. Chem., August 4, 2000; 275(32): 24639 - 24644. [Abstract] |